Edge Biologicals Called Out for Inadequate Procedures, Recordkeeping

Drug Industry Daily
A A
Edge Biologicals was hit with a Form 483 for violations at its Memphis, Tennessee facility, including inadequate environmental monitoring, poor complaint handling and incomplete recordkeeping observed during a March inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily